MP
QTTB icon

Mangrove Partners’s Q32 Bio QTTB Stock Holding History

Mangrove Partners’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$282K Buy
+22,150
New +$185K 0.02% 281

Other funds holding QTTB

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Mangrove Partners's QTTB Position: Q2 2026 in Review

Mangrove Partners opened a new position in Q32 Bio (QTTB) in Q2 2026: 22,150 shares worth $282K. The stake represents 0.02% of the portfolio and ranks #281 among its holdings.

72 funds tracked by Wall St. Rank hold QTTB as of Q2 2026.

  • Mangrove Partners held 22,150 shares of Q32 Bio worth $282K as of Q2 2026.
  • Q32 Bio was a new Mangrove Partners position in Q2 2026.
  • Q32 Bio made up 0.02% of Mangrove Partners's portfolio in Q2 2026, its #281 holding.
  • 72 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2026.

Based on Mangrove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.